Arroyave F, Uscategui Y, Lizcano F
Int J Mol Sci. 2024; 25(17).
PMID: 39273600
PMC: 11395045.
DOI: 10.3390/ijms25179654.
Jarc L, Bandral M, Zanfrini E, Lesche M, Kufrin V, Sendra R
Elife. 2024; 12.
PMID: 38180318
PMC: 10945307.
DOI: 10.7554/eLife.89962.
Goyal P, Malviya R
Endocr Metab Immune Disord Drug Targets. 2023; 24(5):549-561.
PMID: 37861029
DOI: 10.2174/0118715303256582230919093535.
Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E
Nutrients. 2023; 15(9).
PMID: 37432389
PMC: 10180650.
DOI: 10.3390/nu15092217.
Sayed T, Maayah Z, Zeidan H, Agouni A, Korashy H
Cell Mol Biol Lett. 2022; 27(1):103.
PMID: 36418969
PMC: 9682773.
DOI: 10.1186/s11658-022-00397-7.
Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.
Silva I, Kimura C, Colantoni V, Sogayar M
Stem Cell Res Ther. 2022; 13(1):309.
PMID: 35840987
PMC: 9284809.
DOI: 10.1186/s13287-022-02977-y.
In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells.
Le Q, Rodprasert W, Kuncorojakti S, Pavasant P, Osathanon T, Sawangmake C
Sci Rep. 2022; 12(1):9127.
PMID: 35650303
PMC: 9160001.
DOI: 10.1038/s41598-022-13114-3.
Optimizing Generation of Stem Cell-Derived Islet Cells.
Verhoeff K, Cuesta-Gomez N, Jasra I, Marfil-Garza B, Dadheech N, Shapiro A
Stem Cell Rev Rep. 2022; 18(8):2683-2698.
PMID: 35639237
DOI: 10.1007/s12015-022-10391-3.
Retinoic Acid: Sexually Dimorphic, Anti-Insulin and Concentration-Dependent Effects on Energy.
Napoli J
Nutrients. 2022; 14(8).
PMID: 35458115
PMC: 9027308.
DOI: 10.3390/nu14081553.
Identification of an evolutionarily conserved domain in Neurod1 favouring enteroendocrine versus goblet cell fate.
Reuter A, Stern D, Bernard A, Goossens C, Lavergne A, Flasse L
PLoS Genet. 2022; 18(3):e1010109.
PMID: 35286299
PMC: 8959185.
DOI: 10.1371/journal.pgen.1010109.
Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A.
Mere Del Aguila E, Tang X, Gudas L
Oncol Res Treat. 2022; 45(5):291-298.
PMID: 35130553
PMC: 9064920.
DOI: 10.1159/000522425.
Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets.
Miyachi Y, Kuo T, Son J, Accili D
PLoS One. 2021; 16(11):e0260526.
PMID: 34843575
PMC: 8629236.
DOI: 10.1371/journal.pone.0260526.
The Effect and Potential Mechanism of Maternal Micronutrient Intake on Offspring Glucose Metabolism: An Emerging Field.
Wu Y, Zhang Q, Xiao X
Front Nutr. 2021; 8:763809.
PMID: 34746215
PMC: 8568771.
DOI: 10.3389/fnut.2021.763809.
Recapitulating pancreatic cell-cell interactions through bioengineering approaches: the momentous role of non-epithelial cells for diabetes cell therapy.
Ghezelayagh Z, Zabihi M, Kazemi Ashtiani M, Ghezelayagh Z, Lynn F, Tahamtani Y
Cell Mol Life Sci. 2021; 78(23):7107-7132.
PMID: 34613423
PMC: 11072828.
DOI: 10.1007/s00018-021-03951-2.
The Potential of Pancreatic Organoids for Diabetes Research and Therapy.
Bittenglova K, Habart D, Saudek F, Koblas T
Islets. 2021; 13(5-6):85-105.
PMID: 34523383
PMC: 8528407.
DOI: 10.1080/19382014.2021.1941555.
All-trans retinoic acid impairs glucose-stimulated insulin secretion by activating the RXR/SREBP-1c/UCP2 pathway.
Yang H, Liu M, Sheng Y, Zhu L, Jin M, Jiang T
Acta Pharmacol Sin. 2021; 43(6):1441-1452.
PMID: 34417575
PMC: 9160277.
DOI: 10.1038/s41401-021-00740-2.
Engineering islets from stem cells for advanced therapies of diabetes.
Siehler J, Blochinger A, Meier M, Lickert H
Nat Rev Drug Discov. 2021; 20(12):920-940.
PMID: 34376833
DOI: 10.1038/s41573-021-00262-w.
Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects.
Zhou Y, Wang H, Zhou J, Qiu S, Cai T, Li H
Front Endocrinol (Lausanne). 2021; 12:620941.
PMID: 33679618
PMC: 7930481.
DOI: 10.3389/fendo.2021.620941.
Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.
Goenka V, Borkar T, Desai A, Das R
J Diabetes Metab Disord. 2021; 19(2):1979-1993.
PMID: 33520872
PMC: 7843693.
DOI: 10.1007/s40200-020-00647-5.
Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes.
Gheibi S, Singh T, da Cunha J, Fex M, Mulder H
Cells. 2020; 9(11).
PMID: 33198288
PMC: 7696367.
DOI: 10.3390/cells9112465.